The CDC Shooting Proves How Dangerous Misinformation Can Be
It's no surprise, then, that instead of offering a concrete plan to protect staff and rebuild public trust, Health and Human Services Secretary Robert F. Kennedy Jr. seized the tragedy as another opportunity to double down on his dangerous rhetoric.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
ImmunityBio (IBRX) Jumps 14% as on Promising Therapy Candidate Results
We recently published . ImmunityBio, Inc. (NASDAQ:IBRX) is one of the best-performing stocks on Wednesday. ImmunityBio soared by 14.17 percent on Wednesday to close at $2.82 apiece as investors cheered promising early findings from its ongoing trial (QUILT-106) to treat a rare blood cancer type with its therapy candidate. In a statement, ImmunityBio, Inc. (NASDAQ:IBRX) said the first phase of QUILT-106 showed highly promising results in the first two patients with Waldenstrom macroglobulinemia (WM)—a type of non-Hodgkins lymphoma (NHL)—using its CD19 CAR-NK (CD19 t-haNK) natural killer cell therapy. The trial aims to evaluate the safety and efficacy of the cell therapy alone, as well as when it is combined with an existing drug called rituximab. According to ImmunityBio, Inc. (NASDAQ:IBRX), both patients tolerated the therapy candidate without any significant side effects. Notably, all infusions were administered in an outpatient setting. Copyright: katrintimoff / 123RF Stock Photo 'One patient achieved a complete response (CR) with CD19 CAR NK monotherapy, while the second patient achieved CR with CD19 CAR-NK in combination with rituximab. Remission was maintained and is ongoing for six months to date,' ImmunityBio, Inc. (NASDAQ:IBRX) said. While we acknowledge the potential of IBRX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19 minutes ago
- Yahoo
Cantor Weighed Tariff Trades for Hedge Funds But Shut Them Down
(Bloomberg) -- Cantor Fitzgerald LP had internal discussions about facilitating trades for hedge funds based on the outcome of legal challenges to Trump administration tariffs, but shut down the idea before executing any transactions, according to people familiar with the matter. The New York brokerage and investment bank was run for three decades by US Commerce Secretary Howard Lutnick, a key figure in the nation's trade policy, and is now led by his son Brandon. The younger Lutnick was asked in a letter from Democratic Senators Elizabeth Warren and Ron Wyden released Thursday to disclose transactions or agreements the firm has made relating to products that would let institutions effectively bet on the legality of President Donald Trump's tariffs. The US-Canadian Road Safety Gap Is Getting Wider Sunseeking Germans Face Swiss Backlash Over Alpine Holiday Congestion To Head Off Severe Storm Surges, Nova Scotia Invests in 'Living Shorelines' Five Years After Black Lives Matter, Brussels' Colonial Statues Remain For Homeless Cyclists, Bikes Bring an Escape From the Streets Cantor received a client inquiry about possibly facilitating such trades, which are done by larger Wall Street banks, and some staff discussed with potential clients about arranging them before the idea was rejected, said the people, who requested anonymity to describe internal deliberations. The firm takes no directional position on brokered trades, and only takes commission when it matches a buyer and a seller. 'We have not facilitated or executed any trades in that market,' Cantor spokesperson Erica Chase told Bloomberg by phone. Warren and Wyden had cited a late July report by Wired that alleged the financial services company created a 'litigation finance' product that allows it to bet that the courts will strike down the tariffs. In theory, such trades would connect a company vulnerable to US tariffs with a fund willing to bet that such tariffs might be reversed. 'Public reporting indicates that Cantor has offered companies the opportunity to trade their legal claim to a future tariff refund in exchange for 20 to 30% of the duties the company paid,' the letter said. 'In this scenario, if the courts determine that the tariffs are illegal, the company stands to recover hundreds of millions of dollars.' In reference to the cited story from July, Chase, the Cantor spokesperson, said 'what is being reported about our business is absolutely false.' Cantor's dealings have been a key area of focus for ethics watchdogs who are on alert for conflicts of interest, given Lutnick is a prominent figure in shaping Trump's policies and other potentially market-moving matters. Brandon Lutnick has said he wants the firm 'to be sitting at the heart of crypto,' an industry that has boomed under the current administration. Wyden, in an email to Bloomberg, accused Lutnick's son of 'brokering huge bets on policies the Commerce Secretary is personally directing.' 'When you've got the Commerce Secretary's son running the Commerce Secretary's old Wall Street firm,' Wyden wrote, 'you're going to face some tough questions about whether everything is on the level.' Among the questions the senators posed were how many tariff refund agreements Cantor has finalized, whether it created them at the request of a specific client and if anyone at the firm had communicated with people in the US government about the tariffs or related legal cases, including Trump and the Commerce secretary. (Updates with additional details throughout.) Americans Are Getting Priced Out of Homeownership at Record Rates Dubai's Housing Boom Is Stoking Fears of Another Crash Bessent on Tariffs, Deficits and Embracing Trump's Economic Plan Why It's Actually a Good Time to Buy a House, According to a Zillow Economist What Declining Cardboard Box Sales Tell Us About the US Economy ©2025 Bloomberg L.P. Sign in to access your portfolio
Yahoo
19 minutes ago
- Yahoo
HealthPartners launches simple, copay-only health plan
Simplica NextGen Copay plan provides costs up front, lets members compare providers, and can save employers up to 15% compared to other plan options. BLOOMINGTON, Minn., August 14, 2025--(BUSINESS WIRE)--HealthPartners is launching a variable copay benefit plan that aims to provide unparalleled transparency of cost and coverage to members. HealthPartners Simplica NextGen Copay health plan has no deductible or coinsurance for in-network care, and members see what they'll pay up front before scheduling. Copay amounts for specific services at each hospital or clinic vary based on the quality and affordability of the care delivered. A key feature of the plan is the personalized digital experience fully integrated within a member's HealthPartners account. Using HealthPartners' Find Care tool, members can search by condition, provider or service; compare care options; and see their exact copay before scheduling. Members pay less when they choose care with better outcomes. "We developed Simplica in response to the growing demand for more predictable benefits," says Andrea Walsh, HealthPartners president and CEO. "This plan gives members the cost clarity and ease they expect from their health plan and guides them in making informed decisions about where to get the care they need." For example, the copay for an office visit will range from $20 to $150 depending upon the plan option, care site and service. Most same day labs and x-rays are bundled into the copay – helping reduce unexpected costs. Services that may require a separate copay are also visible through the Find Care digital experience. In addition, many virtual care options are covered at a $0 copay. The plan will launch Jan. 1, 2026, and is initially available to large-group, self-insured employers in the Twin Cities metro and surrounding counties. Simplica can save companies up to 15% in claim costs and that translates into savings for employees. "Unlike third-party platforms or standalone applications, Simplica delivers one seamless experience that makes it easier for members and employers to understand and manage costs," says Moe Suleiman, HealthPartners senior vice president of health solutions. "This plan ties copays to provider value, guides members in real time, and delivers the digital-first convenience today's workforce expects." For more information, visit the Simplica NextGen Copay website. About HealthPartners HealthPartners is a nonprofit organization with a mission of improving health and well-being in partnership with its members, patients and community. An integrated system of care and coverage since its founding in 1957, HealthPartners operates hospitals and clinics, health plans, and a research and education institute. The Minneapolis-based organization serves more than 1.3 million patients in Minnesota and Wisconsin and 1.7 million medical and dental health plan members nationwide. For more information, visit View source version on Contacts Amanda
